Clinical Trials Browser

Phase 2 × Rectal Neoplasms × Botulinum Toxins, Type A × Clear all

NCT01589471 2018-02-12

The Value of Botox-A for Management of Low Anterior Resection Syndrome

Phase 2 Completed

Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms